RADAR-CNS

Remote Assessment of Disease and Relapse in Central Nervous System Disorders
RADAR-CNS logo

FACTS & FIGURES

Start Date
End Date
Call
IMI2 - Call 3
Grant agreement number
115902

Contributions
IMI Funding
11 000 000
EFPIA in kind
13 580 029
Other
1 035 832
Total Cost25 615 861

Summary

The RADAR-CNS project aims to develop new ways of monitoring major depressive disorder, epilepsy, and multiple sclerosis using wearable devices and smartphone technology. The key goal of the project is to improve patients’ symptoms and quality of life and also to change how these and other chronic disorders are treated.

Epilepsy, depression, and multiple sclerosis are distinct disorders that affect 400 million people worldwide, with different causes and symptoms, all of which can be severely detrimental to patients’ quality of life and life expectancy. For all three disorders, patients often experience periods where their symptoms are manageable, followed by periods of deterioration and acute illness (relapse). Patient surveys have repeatedly highlighted the need to predict when relapses will happen and to improve the treatments which are available to stop them from occurring. Continuous remote assessment using smartphones and wearable devices provides a complete picture of a patient’s condition at a level of detail which was previously unachievable. Moreover, it could potentially allow treatment to begin before a patient’s health deteriorates, preventing the patient relapsing or becoming more ill before they seek treatment.

Participants Show participants on map

EFPIA companies
  • Biogen Idec Limited, Maidenhead, Berkshire, United Kingdom
  • H. Lundbeck A/S, Valby, Denmark
  • Janssen Pharmaceutica NV, Beerse, Belgium
  • MSD IT Global Innovation Center s.r.o., Prague, Czech Republic
  • UCB Biopharma SPRL, Brussels, Belgium
Universities, research organisations, public bodies, non-profit groups
  • Centro De Investigacion Biomedica En Red, Madrid, Spain
  • Charité – Universitätsmedizin Berlin, Berlin, Germany
  • Fundacio Hospital Universitari Vall D'Hebron - Institut De Recerca, Barcelona, Spain
  • Katholieke Universiteit Leuven, Leuven, Belgium
  • King's College London, London, United Kingdom
  • Northwestern University, Evanston, Illinois, United States
  • Provincia Lombardo-Veneta - Ordine Ospedaliero di San Giovanni di Dio— Fatebenefratelli, Brescia, Italy
  • Region Hovedstaden, Hilleroed, Denmark
  • STICHTING VUmc, Amsterdam, Netherlands
  • Stichting imec Nederland, Eindhoven, Netherlands
  • Universitaetsklinikum Freiburg, Freiburg, Germany
  • University of Nottingham, Nottingham, United Kingdom
  • Università Vita-Salute San Raffaele, Milano, Italy
  • Università degli Studi di Bergamo, Bergamo, Italy
  • Universität Passau, Passau, Germany
Small and medium-sized enterprises (SMEs) and mid-sized companies (<€500 m turnover)
  • Stichting Lygature, Utrecht, Netherlands
Third parties
  • Fundació Sant Joan de Deu, Esplugues de Llobregat, Spain
  • Ospedale San Raffaele, Milano, Italy
  • The Hyve B.V., Utrecht, Netherlands
Non EFPIA companies
  • Intel Corporation (UK) Ltd, Swindon, United Kingdom
  • Software AG, Darmstadt, Germany

CONTACT

Project coordinator
Matthew Hotopf
King's College London
00442078480120
matthew.hotopf[at]kcl.ac.uk
Project leadership
Vaibhav A. Narayan
Janssen Research & Development
VNaray16[at]its.jnj.com